Pharmacy benefit managers are the middlemen in the prescription drug market. The Federal Trade Commission reports the revenue of four PBMs exceeds $1 trillion and they control 86% of the market.
"Given the fact that there are states, counties, cities, school districts, pension funds, and other plaintiffs from all over ...
Sen. James Lankford has been trying to pass legislation in response to an industry he believes will leave small towns without ...
The industry says it keeps down the cost of prescription drugs, but critics say it's profiting at the expense of patients.
Dealbreaker on MSN13d
Pharmacy Benefit Managers Not Thrilled With FTC Report Finding Pharmacy Benefit Managers Raise Drug PricesThe pressure against pharmacy benefit managers (PBMs) continues to build. On Tuesday, the Federal Trade Commission released ...
The report shows that PBMs made over $7.3 billion in extra profits from dispensing specialty generic drugs during the study ...
In late December, President-elect Donald Trump put pharmacy benefit managers ... Warren and activist regulators at Joe Biden’s Federal Trade Commission, which dropped a report just days before ...
KSNF Joplin on MSN13d
Hawley and Warren team up against Pharmacy Benefit ManagersA Missouri lawmaker is putting the high price of medication under the microscope. “My biggest issue is these PBMs, and what ...
At a public meeting held on January 15, 2025, the Federal Trade Commission (FTC) summarized the Second Interim Staff Report ...
The Federal Trade Commission published a second interim staff report this week on the prescription drug middleman industry, which ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback